Court of Justice: Judgment in C-125/10 Merck Sharp & Dohme Corporation
MLex Summary: The Court of Justice has ruled that supplementary protection certificates can be granted for medicinal products where the duration between the basic patent application and the first EU marketing...To view the full article, register now.
Already a subscriber? Click here to view full article